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Profibrinolytic Effects of Metalloproteinases during
Skin Wound Healing in the Absence of Plasminogen
Kirsty A. Green1, Kasper Almholt1, Michael Ploug1, Birgitte Rønø1, Francis J. Castellino2, Morten Johnsen3,
Thomas H. Bugge4, John Rømer1 and Leif R. Lund1
Genetic ablation of plasminogen (Plg) and pharmacological inhibition of metalloproteinase activity by galardin
delay skin wound healing in mice, whereas the combined inhibition of these two enzyme systems completely
prevents healing. In this study, the impact of plasmin and metalloproteinases as profibrinolytic enzymes has
been investigated by comparing skin wound healing in the absence and presence of fibrin. Plg deficiency
impairs skin wound healing kinetics, but this delay is only partially restored in the absence of fibrin. This
suggests that plasmin-mediated fibrinolysis is the primary, but not the exclusive, requirement for healing of
wounds in these mice. In addition, we observe that lack of fibrin reduces Plg activation significantly during
wound healing. The profibrinolytic role of metalloproteinases is revealed by the finding that lack of fibrin
partially restores the otherwise arrested healing of Plg-deficient wounds after metalloproteinase inhibition. In
conclusion, the residual impairment of skin wound healing in the absence of fibrin suggests the existence of a
fibrin-independent substrate(s) for plasmin and metalloproteinases. Furthermore, these in vivo data reveal that
galardin-sensitive metalloproteinases mediate compensatory fibrinolysis to facilitate wound healing in the
absence of plasmin.
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INTRODUCTION
Proteolytic degradation of the extracellular matrix by the
serine protease plasmin and members of the matrix metallo-
proteinase (MMP) family plays a key role in a variety of
physiological and pathological processes that involve tissue
remodeling and cell migration (Danø et al., 1999; Coussens
et al., 2000; Egeblad and Werb, 2002; Page-McCaw et al.,
2007). Plasmin is formed from plasminogen (Plg) by
proteolytic cleavage catalyzed by specific Plg activators.
Hepatically produced Plg is present in high concentrations in
plasma and interstitial fluids, and represents a large reservoir
of proteolytic potential available for local activation through-
out the body by its activators. Three physiologically active
mammalian Plg activators are known, the urokinase type
(uPA), tissue type (tPA) (Danø et al., 1985; Collen and Lijnen,
2005), and a newly identified Plg activator, plasma kallikrein,
demonstrated to activate Plg during adipocyte differentiation
(Selvarajan et al., 2001) and recently during wound healing
(Lund et al., 2006). It is well established that Plg deficiency
has serious physiological consequences in both humans and
mice (Bugge et al., 1995; Mingers et al., 1997; Schuster et al.,
1997; Drew et al., 1998). A role for plasmin in tissue
remodeling processes has been conclusively demonstrated by
studies of skin wound healing (Rømer et al., 1996), cancer
metastasis (Bugge et al., 1998), post-lactational mammary
gland involution (Lund et al., 2000), placental development
(Solberg et al., 2003), and neointima formation after vascular
injury (Lijnen et al., 1998) in mice with a disrupted Plg gene.
In Plg-deficient mice, there is a pronounced delay in
healing of skin wounds, characterized by a decreased rate of
keratinocyte re-epithelialization from the wound edges and
an accumulation of fibrin in front of and beneath the leading
edge keratinocytes, suggesting that the delay is due to a
diminished ability of these cells to proteolytically dissect their
way through the fibrin-rich provisional wound matrix (Rømer
et al., 1996). During the invasive phase of wound healing, the
migrating leading edge keratinocytes express uPA and its cell
surface receptor uPAR. tPA is more scarcely expressed, but
has been detected in a few keratinocytes late in the re-
epithelialization of human wounds and also accumulates in
wound fields due to its high affinity for fibrin (Grøndahl-
Hansen et al., 1988; Rømer et al., 1991, 1994; Drew et al.,
2001). Furthermore, we have previously demonstrated that
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lack of fibrin(ogen) in the wound field could rescue the
requirement for Plg to achieve timely healing (Bugge et al.,
1996b).
In addition to the expression of Plg activation components,
several members of the MMP family, including MMP-3,
MMP-9, and MMP-13, are expressed in the leading edge
keratinocytes in mice (Madlener et al., 1998; Lund et al.,
1999). The MMP family consists of more than 20 Zn-
dependent endoproteases that are important for a number of
tissue remodeling processes (Egeblad and Werb, 2002;
Puente et al., 2003). Treatment of wild-type mice with the
broad-spectrum metalloproteinase inhibitor galardin, which
inhibits a number of metalloproteinases (Saghatelian et al.,
2004), including MMP-3, MMP-9, and MMP-13 (Grobelny
et al., 1992; Levy et al., 1998), causes a delay in wound
healing (Lund et al., 1999). Although delayed, complete
wound healing is eventually achieved in all galardin-treated
wild-type mice and all untreated Plg-deficient mice. How-
ever, when Plg-deficient mice are treated with galardin,
healing is completely arrested, demonstrating that protease
activity is essential for wound healing and that there is a
functional overlap between the two different classes of
matrix-degrading proteases in this process (Lund et al., 1999).
Here, we have investigated the contribution of impaired
fibrin degradation to the wound healing kinetics by compar-
ing wound healing in Plg-deficient mice, galardin-treated
wild-type mice, and galardin-treated Plg-deficient mice with
the wound healing after genetically superimposing fibrinogen
(Fib) deficiency. We show that reduced fibrinolysis is the
primary impediment to the healing of large incisional skin
wounds in Plg-deficient mice regardless of whether these are
galardin-treated or not. Nonetheless, the phenotypes of Plg-
deficient mice are not completely reversed by simultaneous
Fib deficiency, suggesting a fibrin-independent substrate for
plasmin during wound healing. Importantly, we find that Plg
activation in the wounds is dependent on the presence of a
fibrin-rich provisional matrix. We further demonstrate that
although reduced fibrinolysis is not the primary impediment
to wound healing in galardin-treated wild-type mice,
galardin-sensitive MMPs are able to provide compensatory
fibrinolysis that allows wound healing to proceed in the
absence of Plg.
RESULTS
Partial compensatory effect of Fib deficiency on the healing of
wounds in Plg-deficient mice
To perform a meticulous comparison of the profibrinolytic
contributions of Plg and MMPs during wound healing in vivo,
we studied the kinetics of this process in mice with selected
combinations of gene deficiencies. Central to these studies is
the high reproducibility of our model system in which
standardized incisional, 20-mm-long full-thickness wounds
were generated in wild-type mice (n¼ 16), Fib-deficient mice
(n¼16), Plg-deficient mice (n¼12), and mice double-
deficient for Fib and Plg (n¼12). The lesions were examined
by visual inspection, and the wound lengths were measured
every second day. Immediately after surgery, the wounds
in mice of all genotypes were spindle shaped, with
well-separated incision edges and underlying muscle fascia
being exposed. By the second day after wounding, the
wounds in wild-type and Plg-deficient mice were all covered
by a dehydrated wound crust, whereas the wounds of both
Fib-deficient and Fib/Plg double-deficient mice remained
open and leaking, with swollen and edematous wound edges.
The crust in wild-type and Plg-deficient mice was gradually
lost as healing progressed, whereas the wounds of both Fib-
deficient and Fib/Plg double-deficient mice remained leaky
and increasingly circular without a regular wound crust up to
14 days after wounding (Figure 1a). The lesions were judged
by gross inspection, and scored as healed when there was a
complete loss of the wound crust and closure of the incision
interface with restoration of the epidermal covering. Macro-
scopic evaluation of the wound geometries revealed a slightly
impaired contraction in the Fib and Fib/Plg-deficient mice in
the very early processes of healing (0–5 days after wounding)
as evident from the relatively larger wound widths observed
in these genotypes (Figure 1b, bottom). However, this initial
difference between the genotypes is lost after day 5 and only
the Plg single-deficient mice exhibited a delayed wound
healing in the later phases, where the re-epithelialization
normally occurs by a prominent keratinocyte migration (see
later). The mean time to complete healing for wild-type mice
was 16.4 days. In Fib-deficient mice, the mean healing time
was only slightly increased to 18.5 days (P¼0.04), whereas
the mean healing time of wounds in Plg-deficient mice was
increased to 39.2 days (P¼0.0015) (Figure 1b). Wounds in
Fib/Plg double-deficient mice healed much faster than the
wounds in Plg single-deficient mice (22.2 vs 39.2 days;
P¼0.009), indicating that fibrin accumulation is the major
impediment to wound healing in Plg-deficient mice and that
fibrin is the principal substrate for plasmin during wound
healing. However, the double-deficient mice showed a mean
healing time that was significantly longer when compared
with wild-type mice (22.2 vs 16.4 days; Po0.0001) and mice
with a single deficiency in Fib (22.2 vs 18.5 days; P¼0.0035)
(Figure 1b). This emphasizes that in this reproducible model,
loss of Fib does not completely rescue the impaired wound
healing in Plg-deficient mice inflicted with large 20mm long
wounds. The same conclusion was reached in an additional
study of 15mm long wounds (data not shown).
Aberrant re-epithelialization in Fib-deficient and Fib/Plg
double-deficient mice
We next examined 20mm long wounds from wild-type,
Fib-deficient, Plg-deficient, and Fib/Plg double-deficient
mice at 2, 7, and 10 days after wounding by histological
methods. In both wild-type and Plg-deficient mice, the
wounded area is covered by a wound crust and provisional
matrix at 2 days after wounding and there is no apparent
migration of keratinocytes at this time point (Figure 2a and g).
Keratinocyte migration is first evident at 7 and 10 days after
wounding (Figure 2b, c, h, and j). After 10 days, the
keratinocytes have covered or almost covered the wound in
wild-type mice, and the provisional matrix is replaced by a
well-organized granulation tissue (Figure 2c). The re-epithe-
lialization is severely retarded in Plg-deficient mice 10 days
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after wounding (Figure 2j). In contrast, there is no apparent
provisional matrix or wound crust in either Fib-deficient or
Fib/Plg double-deficient wounds at any of the time points
analyzed (Figure 2d–f and k–m). Instead of using the
provisional matrix as a substrate for migration, the keratino-
cytes move along the surfaces of the tissue resulting in a
clearly aberrant re-epithelialization pattern (Figure 2f and m).
We quantified the impact of Fib deficiency, Plg deficiency,
and Fib/Plg double deficiency on re-epithelialization by
morphometric analysis. This was done by calculating the
relative migration distance of the keratinocytes inward from
the wound edges. We found the relative migration distances
of the keratinocytes at day 10 after wounding to be
significantly different between the wild-type and Plg-deficient
wounds, as reported previously (Rømer et al., 1996; Lund
et al., 2006). The aberrant pattern of re-epithelialization of
Fib-deficient and Fib/Plg double-deficient mice complicates
the interpretation of the migration distance measurements in
these genotypes and excludes a direct comparison of this
parameter between Fib-deficient and Fib-sufficient mice.
Whereas Fib-sufficient mice exhibited a significant reduction
(P¼0.003) of the migration distance in the absence of Plg
(Figure 2n), such differences in the relative migration
distances were not observed in Fib-deficient mice with or
without Plg (Figure 2o).
Fibrin accumulates in front of leading edge keratinocytes in
Plg-deficient mice
We next used double immunofluorescence staining of tissue
sections for fibrin(ogen) and cytokeratin to visualize fibrin
(ogen) and keratinocytes in the wounds (Figure 3). This
analysis demonstrated an accumulation of fibrin underneath
and in some cases in front of the migrating keratinocytes in
Plg-deficient wounds (Figure 3a), whereas no fibrin was
detectable beneath the adjacent non-injured skin (data not
shown). Compared with the sporadically fenestrated fibrin
staining seen in wild-type mice, the wounds in Plg-deficient
mice showed an almost confluent fibrin staining in the same
areas (Figure 3a and b), suggestive of an additional fibrin
accumulation in the absence of Plg. In the Fib-deficient and
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Figure 1. Time course of skin wound healing in wild-type, Fib-deficient, Plg-deficient, and Fib/Plg double-deficient mice. (a) Representative examples of the
progress of wound repair processes in wild-type, Fib-deficient, Plg-deficient, and Fib/Plg double-deficient mice. (b) The percentage fraction of mice with
complete re-epithelialization is plotted vs time after incision of 20mm long wounds. The severely impaired wound healing in Plg-deficient mice is to a large
extent rescued in Fib/Plg double-deficient mice. Wound healing in Fib/Plg double-deficient mice is still significantly delayed compared to wild-type mice,
whereas mice with a single deficiency in Fib show only a modest delay in healing time. Wound geometries (length and width) were measured every second day
for the individual single- and double-deficient genotypes and are plotted as a function of time in the middle and lower panel, respectively.
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Fib/Plg double-deficient wounds used as controls, no specific
immunofluorescence was detected (Figure 3c and d). We
next tested whether lack of fibrin or the observed differences
in fibrin accumulation between Plg-deficient and Plg-
sufficient mice affected the leading edge keratinocyte
expression of the laminin-5 (laminin-332) g2 chain, which
is a marker for migrating keratinocytes (Larjava et al., 1993;
Pyke et al., 1994). Immunohistochemical staining for the
laminin-5 g2 chain revealed no differences in staining
intensity or localization in or beneath the migrating basal
keratinocytes between any of the four genotypes analyzed
(data not shown).
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Figure 2. Kinetics of re-epithelialization in skin wounds from wild type, Fib-deficient, Plg-deficient and Fib/Plg double-deficient mice. Re-epithelialization
of incisional wounds is visualized by immunostaining of keratinocytes with anti-mouse keratins 10 and 14 in wild type (a–c), Fib-deficient (d–f), Plg-deficient
(g–j), and Fib/Plg-deficient (k–m) mice. The leading edge keratinocytes are indicated by solid arrows, whereas the open arrow highlights the complete restoration
of the epidermal surface in a wild-type wound. The star indicates the lack of a provisional matrix in the absence of fibrin (e, f, l, and m). Scale bar¼ 1mm.
(n and o) Quantitative evaluation of the relative migration distance of keratinocytes measured at day 10. With this method, complete re-epithelialization is
scored as 1.0 and each data point refers to an individual wound. The mean values are depicted as horizontal lines. The migration of keratinocytes in Plg-deficient
wounds is significantly decreased compared with wild-type wounds (see panel n, P¼ 0.003). In contrast, there is no difference between the keratinocyte
migration distances in Fib-deficient and Fib/Plg double-deficient wounds (see panel o).
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Activation of Plg in the wound field is dependent on the
presence of a fibrin-containing provisional matrix
As fibrin is the principal substrate for plasmin, we next
examined the Plg activation status in wound extracts pooled
from three mice of each of the relevant genotypes. The
excised wounds were lysed by ultrasonication in the presence
of 10 mgml1 aprotinin, and Plg derivatives were affinity-
purified on a lysine-Sepharose microcolumn (Lund et al.,
2006). The eluates were analyzed by SDS-PAGE followed by
either silver staining or western blot analysis using a
polyclonal anti-human Plg antibody (Ab) that crossreacts
with murine Plg (Figure 4a and b). In the reduced and
alkylated samples, the A-chain of plasmin, but not the
B-chain, was detected in wounds from wild-type mice,
whereas neither A- nor B-chains were detected in non-
injured skin or plasma by silver staining or western blotting
(Figure 4a). Surprisingly, the A-chain was also undetectable
in wound extracts from Fib-deficient mice. Parallel studies
performed under non-reducing conditions revealed
the presence of a stable complex between plasmin and
a2-antiplasmin (a2AP) in the wound extracts from wild-type
mice, whereas this complex was undetectable in Fib-
deficient mice, non-injured wild-type skin, and plasma
(Figure 4b). In addition to this covalent serpin–plasmin
complex, we also observed a number of fragments derived
from the Plg A-chain (that is, K1–K5 and K1–K3). Peptide mass
mapping by matrix assisted laser desorption ionization mass
Wild type
Fib–/–
Plg–/–
Fib–/–/Plg–/–
Figure 3. Fibrin accumulation in the provisional matrix of skin wounds as
revealed by immunofluorescence. Tissue sections of 10-day-old wounds from
Plg-deficient (a), wild-type (b), Fib-deficient (c), and Fib/Plg double-deficient
(d) mice were stained by immunofluorescence with antibodies to cytokeratin
8 (red) and fibrin(ogen) (green) accompanied by nuclear staining with
Hoechst (blue). The tip of the leading edge keratinocytes is shown for
each genotype (closed arrows). In the wild-type wound, the keratinocytes
migrate through the fibrin matrix, whereas in the Plg-deficient wound, the
migrating tip is blunt-ended and a dense accumulation of fibrin is observed in
front of and under the migrating keratinocytes (open arrows). As expected, no
signal for fibrin is detectable in the Fib-deficient and Fib/Plg double-deficient
wounds.
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Figure 4. Attenuated plasmin generation in skin wounds from Fib-deficient
mice. Plasminogen-derived fragments and complexes were purified from
murine tissue extracts (pools of three mice) and plasma by lysine-Sepharose
affinity chromatography. (a) An analysis of these purified components by SDS-
PAGE after reduction and alkylation followed by either silver-staining (left) or
western blotting using a polyclonal anti-plasminogen (Plg) antibody (right). (b)
The corresponding analysis of unreduced samples. The skin extracts analyzed
are from non-injured wild-type skin (lanes 2 and 9), wild-type wounds (lanes
3 and 10), Fib-deficient wounds (lanes 4 and11), and
Plg-deficient wounds (lanes 5 and 12). Purified Plg from wild-type plasma
served as control before (lanes 6 and 13) and after uPA-mediated in vitro
conversion to plasmin in the presence of 10 mgml1 aprotinin
(lanes 7 and 14). (c) Crude extracts of 7-day-old incisional wounds from
individual mice were analyzed for Plg conversion by western blotting after
reduction and alkylation (16 ml extract applied in each case). Extracts
prepared from three wild-type mice are analyzed (lanes 3–5) and those
from 5 Fib-deficient mice (lanes 6–10). To control for nonspecific
binding, 16 ml of extract from a Plg-deficient wound were analyzed in parallel
(lane 11) and 2 ml of plasma from a wild-type mouse served as a positive
control (lane 2).
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spectrometry (MALDI-MS/MS) sequencing after in-gel diges-
tion of the excised bands confirmed the identity of the
plasmin  a2AP complex as well as the A-chain fragments
shown in Figure 4a and b (data not shown). The identity of the
plasmin  a2AP complex was further substantiated by a
comparison of the electrophoretic mobility of complexes
formed in vitro and by its reactivity with anti-Plg (Figure 4b,
right panel) and anti-a2AP Abs in western blotting (data not
shown). Identification of the plasmin  a2-macroglobulin
complex was based on a comparison of electrophoretic
mobility with complexes formed in vitro (data not shown).
Despite the lack of detectable plasmin formation in the
absence of fibrin, the phenotypic difference observed
between the healing times in Fib-deficient and Fib/Plg
double-deficient mice (Figure 1b) may indicate that minor
amounts of plasmin are actually formed in the Fib-deficient
mice. Nonetheless, these biochemical data demonstrate a
significant role in vivo of local fibrin deposition for Plg
activation during wound healing as evident from the specific
accumulation of inhibited plasmin complexes in the wild-
type wounds only. This genotype-specific Plg activation was
not influenced by the lysine-Sepharose chromatography, as a
similar activation status was observed by western blotting
using crude wound extracts from individual mice (Figure 4c).
Lack of fibrin decreases wound healing times in galardin-treated
Plg-deficient mice, but not in galardin-treated wild-type mice
We previously demonstrated that the broad-spectrum metal-
loproteinase inhibitor galardin delays wound healing in wild-
type mice and that wound healing in galardin-treated Plg-
deficient mice is completely blocked (Lund et al., 1999). To
explore the impact of fibrin(ogen) under these conditions, we
next examined the contribution of impaired fibrin degrada-
tion to wound healing kinetics in galardin-treated wild-type
mice and in galardin-treated Plg-deficient mice. Galardin
treatment increased the mean wound healing time in wild-
type mice (n¼ 15) to 24.9 days compared with 17.5 days
in mock-treated wild-type mice (n¼ 19) (Po0.0001)
(Figure 5a). Similarly, the mean wound healing time of
galardin-treated Fib-deficient mice (n¼ 7) was increased to
29.7 days compared with 19.3 days in mock-treated Fib-
deficient mice (n¼ 11) (P¼0.021) (Figure 5b). There was no
significant difference in the healing times between galardin-
treated wild-type mice and galardin-treated Fib-deficient
mice (24.9 vs 29.7 days; P¼0.12) (compare Figure 5a and b).
This indicates that reduced fibrinolysis is not the major cause
of the delayed wound healing in galardin-treated Plg-
sufficient mice. No appreciable wound healing takes place
in galardin-treated Plg-deficient mice (n¼11) (Figure 5c).
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Figure 5. Effect of pharmacological inhibition of metalloproteinase activity on the healing kinetics of skin wounds in mice genetically deficient in Fib and Plg.
The percentage of mice with complete healing is plotted vs time after incision of the skin. Wild-type (a), Fib-deficient (b), and Fib/Plg-deficient (d) mice treated
with a metalloproteinase inhibitor (galardin, in red) exhibited a significant delay in healing compared with vehicle-treated mice (in black). In contrast, inhibitor
treatment of Plg-deficient mice (c) completely blocked the repair process. This blockage of wound healing was reversible, as cessation of galardin treatment at
50 days after wounding (arrow in c) reinstated the healing process. Within 36 days after galardin withdrawing, all the wounds of these mice were completely
covered with a new epidermal layer.
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Importantly, when Fib deficiency is superimposed on this
phenotype, the resulting galardin-treated Fib/Plg-deficient
mice (n¼8) displays only a modest delay in wound healing
compared with mock-treated Fib/Plg-deficient mice (n¼12)
(26.8 vs 21.0 days; P¼ 0.012) (Figure 5d). This shows that
galardin-sensitive MMPs are profibrinolytic in the absence of
Plg and that the complete loss of healing capacity in galardin-
treated Plg-deficient mice is largely attributable to the
inability to proteolytically remove accumulated fibrin from
the wound field.
DISCUSSION
In this study, we have shown that galardin-sensitive
metalloproteinases are endowed with profibrinolytic activity
in vivo, as they, to some extent, can substitute for Plg in the
removal of fibrin during skin wound healing in a reproducible
mouse model. Another important conclusion from these
studies is that although the primary impediment to the
healing of wounds in Plg-deficient mice is compromised
fibrin dissolution, it is not the only defect. This indicates that
plasmin has other as yet unidentified substrates during skin
wound healing. Intriguingly, these experiments also highlight
the importance of a Fib/fibrin matrix in the biochemical
activation of Plg in vivo.
Using an identical genetic approach, it was previously
reported that removal of fibrin(ogen) from the wound field
negates the requirement for Plg for timely healing (Bugge
et al., 1996b), suggesting that plasmin-mediated fibrinolysis is
the only rate-limiting factor in the dissolution of the
provisional matrix in the wound field. Nevertheless, in this
study, we consistently find a small, but significant, residual
impairment in the healing kinetics of wounds in Fib/Plg
double-deficient mice compared to littermate wild-type
controls. The reason for the discrepancy between the two
studies is at present unknown, but it may have a bearing on
the differences in genetic background of the mice, wound size
and geometry, and animal housing facilities. These variations
in the experimental conditions may have caused shorter
healing times (11–13 days) in the previous study (Bugge et al.,
1996b) compared with a mean healing time of 16.4 days in
this study, thus providing a larger dynamic range in the latter
study enabling the identification of minor differences between
genotypes. Therefore, our study provides clear evidence that
plasmin cleavage of substrates different from fibrin(ogen) is
ultimately rate-limiting for incisional skin wound healing, as
also reported previously for the removal of necrotic hepatic
debris after carbon tetrachloride intoxication of Plg-deficient
mice (Bezerra et al., 1999). Extracellular proteases have
pleiotropic functions in tissue repair (Page-McCaw et al.,
2007). Besides the removal of provisional extracellular matrix,
these include the liberation of latent growth factor precursors
from the cell surface and the extracellular matrix, the
activation of protease activated receptors, the shedding of
growth factor and cytokine receptors, and the generation of
chemotactic degradation products of extracellular matrix.
Identification of the relevant non-fibrin(ogen) substrates
cleaved by plasmin during skin wound healing, therefore
represents, a challenging enterprise.
It is well established that intravascular plasmin generation
is strictly confined to the dissolving thrombus, as explained
by the very potent stimulation of tPA activity by fibrin, and by
the protection of fibrin-bound plasmin from neutralization by
its endogenous inhibitors (Collen and Lijnen, 2005). An
unanticipated finding in this study was that plasmin genera-
tion is also strongly dependent on fibrin(ogen) in the
extravascular environment of a wound field. This is particu-
larly unexpected, as we have previously shown that uPA,
which has no known fibrin-stimulated Plg activator activity,
has the major impact on plasmin generation during skin
wound healing compared to tPA (Lund et al., 2006).
Intriguingly, this suggests that fibrin(ogen) is also a potent
promoter of the reciprocal pro-uPA/Plg zymogen activation
in vivo and that this effect may be well governed by the
resistance of fibrin-bound plasmin toward inhibition by
a2AP and a2-macroglobulin. Nevertheless, studies on a
combined deficiency of both uPA and tPA demonstrate an
important functional overlap of these enzymes in skin wound
healing and plasmin generation (Bugge et al., 1996a; Lund
et al., 2006). Detailed studies of plasmin generation in tPA-
deficient mice with and without a genetic superposition of
fibrin(ogen) deficiency would be excellently suited to further
investigate this interesting phenomenon. Our findings also
raise the rather curious possibility that the minor, but
significant, delay in wound healing observed here in Fib-
deficient mice may be caused by the loss of fibrin(ogen)-
dependent plasmin formation and the subsequent absence of
plasmin cleavage of non-fibrin(ogen) substrates. Nonetheless,
it should be emphasized that this observation could
equally be well rationalized by the absence of specific
fibrin-derived bioactive peptides in the Fib-deficient mice,
which normally would provoke a pro-inflammatory response
in the provisional matrix by recruitment of neutrophils
and monocytes, and the absence of these stimuli would
cause the observed delay in wound healing (Richardson
et al., 1976; Gross et al., 1997; Laurens et al., 2007). An
analogous pro-inflammatory role of transforming
growth factorb has been proposed to influence wound
healing (Wahl et al., 1987).
We have previously demonstrated a functional overlap
between Plg and galardin-sensitive metalloproteinases during
skin wound healing (Lund et al., 1999, 2006). We now
provide previously unidentified mechanistic insights into this
phenomenon by showing that fibrin(ogen) is an important
mutual substrate for the two extracellular proteolytic systems.
Furthermore, we show that metalloproteinase-mediated fibrin
dissolution becomes functionally important only when
plasmin generation is absent, but fibrin(ogen)-independent
metalloproteinase activity is quantitatively important for
wound healing both in the presence and absence of Plg.
Our data are concordant with previous studies showing that
some MMPs are endowed with significant fibrinolytic
capacity in cell-based ex vivo models of cell migration
(Hiraoka et al., 1998; Hotary et al., 2002). We previously
reported that most cell types critical to skin wound healing,
including endothelial cells, fibroblasts, and inflammatory
cells, accumulate at normal rates in the Plg-deficient wound
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field and that the subsequent granulation tissue formation
involving these cells is seemingly unimpaired by the absence
of Plg (Rømer et al., 1996). This strongly suggests that the
compensatory fibrinolysis mediated by galardin-sensitive
metalloproteinases during healing of Plg-deficient wounds
is directly related to the dissolution of fibrin required for the
migration of granulation tissue cells and keratinocytes into
the fibrin-rich provisional matrix during tissue repair. This
hypothesis is in excellent agreement with our previous
demonstration of a colocalization of Plg activator (uPA) and
several galardin-sensitive metalloproteinases (MMP-3, MMP-
9, MMP-13) in leading edge wound keratinocytes (Lund
et al., 1999), which may explain the complete arrest of
keratinocyte migration at the wound edge of galardin-treated
Plg-deficient mice.
In summary, our studies have revealed that galardin-
sensitive metalloproteinases are equipped with profibrino-
lytic activity during skin wound healing, the existence of
fibrin(ogen)-independent substrates for both Plg and galardin-
sensitive metalloproteinases that are quantitatively relevant to
skin wound healing, and uncovered a strict requirement for
fibrin(ogen) in the generation of plasmin within the extra-
vascular environment of a healing wound.
MATERIALS AND METHODS
Animals and animal treatment
Fib gene-targeted mice on a C57BL/6J background (Ploplis et al.,
2000) were backcrossed into an FVB/n background (Panum Institute,
Copenhagen, Denmark) for eight generations, as less than 5% Fib-
deficient mice born on a C57BL/6J background survived to weaning.
Heterozygous mice were crossed with heterozygous Plg mice
backcrossed to C57BL/6J for 22 generations to obtain an F1
generation of double heterozygous Fibþ //Plgþ / siblings. These
double-deficient heterozygous mice were crossed to obtain an F2
generation of siblings, which revealed the expected Mendelian
distribution. Chromosomal DNA from an approximately 2mm piece
of tail tip was isolated as described (Lund et al., 1999). The Plg
genotype was determined as described (Bugge et al., 1996b). The Fib
genotype was determined by multiplex PCR using the following
three primers. mfib(g)-1p (GTGCCACAGCTGCTTGTCATTAG) hy-
bridizing to position 10 138–10 160 in the mouse Fib(g) gene
(GenBank: CAAA01040047); mfib(g)-2m (ATGCTGGAGATG
GGTTCCTGTC) hybridizing to position 10 449–10 470 generate a
333 bp product specific for the endogenous allele; and mfib(g)-1p
and Neo-3p (TCAGCAGCCTCTGTTCCACATAC) hybridizing within
the neomycin cassette generate a 499 bp product specific for the
targeted allele.
All mice used for experiments were between 6 and 8 weeks old at
the start of the experiment. Investigators unaware of the mouse
genotype performed all experimental evaluations, tissue isolations,
and microscopic analyses. The MMP inhibitor N-[(2R)-2-(hydro-
xamido-carbonylmethyl)-4-methylpentanoyl]-L-tryptophanmethyla-
mide (Galardin) was synthesized as described (Grobelny et al.,
1992). Galardin was clinically formulated as a 20mgml1 slurry in
4% carboxymethylcellulose in phosphate-buffered saline (PBS)
and was administered daily intraperitoneally at 100mg per kg
body weight. Mock treatment included 4% carboxymethylcellulose
in PBS.
Tissue preparation
Six- to eight-week old mice were anesthetized by subcutaneous
administration of 0.03ml per 10 g of a 1:1 mixture of Dormicum
(Midazolam 5mgml1) and Hypnorm (Fluanison 5 and Fentanyl
0.1mgml1) before surgery. Incisional skin wounds of 15- or 20-
mm-long full-thickness were made middorsally with a scalpel. The
wounds were neither dressed nor sutured. The mice were caged
individually until killing, at the time they were anesthetized as
described above, followed by perfusion fixation with PBS and 4%
paraformaldehyde. The wound areas were removed, bisected in the
midtransversal plane, fixed in 4% paraformaldehyde overnight and
then paraffin-embedded as described previously (Lund et al., 1999).
The sections were cut perpendicular to the longitudinal direction of
the wounds. For histological analysis, a total of 90 mice were
wounded, from which tissue was isolated for each genotype (wild
type, Fib-deficient, Plg-deficient, and Fib/Plg double-deficient) at
day 2 after wounding from 5, 5, 4, and 3 mice of the respective
genotypes; at day 7 from 4, 4, 5, and 5 mice; at day 10 from 8, 9, 10,
and 6 mice; and at the time of healing from 7, 5, 3, and 7 mice.
Animal care at The Department of Experimental Medicine,
University of Copenhagen and Rigshospitalet, Copenhagen, Denmark,
was in accordance with institutional and national guidelines.
Computer-assisted morphometry
Keratinocyte migration was measured microscopically on tissue
sections stained immunohistochemically with anti-mouse keratins
10 and 14 IgG (see below). The length of the epidermal tongue was
measured as the linear distance between the tip of the leading edge
keratinocytes and the edge of the wound, defined as the point in the
zone of proliferation where a shift from two to three layers of
keratinocytes could be identified. The relative migration was
determined as the sum of the lengths of both epidermal tongues
divided by the width of the wound, defined as the linear
distance between the wound edges. The sections used for these
measurements were carefully selected from the midline of the
wound field. Identification of this point in the proliferation zone and
the tip of the epidermal wedge by image analysis were performed
on two sections per wound by an observer unaware of the genotype
of the mice.
Statistical analysis
The StatView software package (version 5.0; SAS Institute, Cary, NC)
was used for statistical analysis. The distribution of time to
macroscopic wound closure and the migration distance of keratino-
cytes in histological sections were found to be normal. Pre-specified
tests of hypothesis comparing experimental groups were carried out
using two sample t-tests. The assumption of variance homogeneity
was tested by the folded F-test, and the two sample t-tests assuming
unequal variances was used if the hypothesis of variance homo-
geneity was rejected. The level of significance was set at 5%.
Immunohistochemistry
Tissue sections were immunohistochemically stained by the
peroxidase anti-peroxidase method with rabbit polyclonal Abs
directed against mouse keratins 10 and 14 (Cappel, Organon
Teknika, PA). Each experiment included controls with omission of
the primary Ab and substitution of the primary Ab with non-immune
rabbit IgG. These were all negative.
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Double immunofluorescence
Tissue sections were de-paraffinized in xylene and hydrated through
graded ethanol/water dilutions. Antigen retrieval was by incubation
with proteinase K for 15minutes at 37 1C. Sections were then
washed in running tap water for 5minutes and Tris-buffered saline
(TBS: 50mM Tris, 150mM NaCl, pH 7.6) for 5minutes. The slides
were then mounted with TBS containing 0.5% Triton X-100 in
immunostaining chambers (Thermo Shandon, cat. no. 7211013,
Pittsburgh, PA) for subsequent incubations. Slides were incubated
overnight together with rabbit anti-mouse fibrin(ogen) Ab (1:2,000;
Bugge et al., 1995) and rat anti-mouse cytokeratin-8 Ab (clone
Troma-1, 1:100; Kemler et al., 1981) in TBS containing 0.25% BSA
at 4 1C. All Ab incubations were followed by washes in TBS. Rabbit
anti-fibrin(ogen) Ab was detected with Alexa Fluor 488-linked
donkey anti-rabbit Ab (1:200, cat. no. A21206; Molecular Probes,
Carlsbad, CA), and rat anti-cytokeratin-8 Ab was detected with Alexa
Fluor 594-linked goat anti-rat Ab (1:200, cat. no. A11007; Molecular
Probes) in TBS containing 0.25% BSA for 45minutes at ambient
temperature. The slides were counterstained with Hoechst 33342
(1:5,000, cat. no. H3570; Molecular Probes) in TBS for 10minutes at
ambient temperature and mounted in fluorescent mounting medium
(cat. no. S3023; DakoCytomation, Glostrup, Denmark). Negative
controls without anti-fibrin(ogen) primary Ab were negative for
unspecific staining.
Western blot analysis
Frozen tissue powder containing both the wound rim and granula-
tion tissue (pool of three mice per genotype) was resuspended in 5ml
extraction buffer (0.1 M Tris/HCl (pH 7.4) containing 10 mgml1
aprotinin) per milligram wet weight tissue and treated for 2 8min-
utes in an ultrasonication bath. The resulting supernatants were
collected after centrifugation at 12,000 g for 30minutes at 4 1C. After
SDS-PAGE, the samples were transferred to polyvinylidene difluor-
ide membranes by electroblotting, and additional binding was
blocked by incubation for 1 hour at room temperature with either
5% non-fat-dried milk (crude lysates) or 2% BSA (purified Plg
preparations) in PBS containing 0.05% Tween-20 (PBS-T). Primary
Ab was incubated overnight at 4 1C with 0.1 or 0.5 mgml1
polyclonal rabbit anti-human Plg Ab (cat. no. A0081; DakoCytoma-
tion). After washing in PBS-T (5 5minutes), membranes were
incubated for 1.5 hours at room temperature with horseradish
peroxidase-linked secondary Ab (cat. no. P0217, 1:5,000; Dako-
Cytomation) in blocking buffer. After washing in PBS-T and PBS,
horseradish peroxidase activity was detected using enhanced
chemiluminescence reagents (Amersham Biosciences, Hillerød,
Denmark). Mouse Plg purified from plasma served as controls as
did plasmin generated in vitro from purified mouse Plg by uPA
activation in the presence of 10 mgml1 aprotinin. A negative control
without primary Ab included was carried out in parallel.
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